Canaccord Reiterates Buy Rating on Boston Scientific (BSX)

July 28, 2026 5:24 AM EDT Send to a Friend
Canaccord analyst William Plovanic reiterated a Buy rating and $70.00 price target on Boston Scientific (NYSE: BSX)The analyst comments "Bottom ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login